Molecular cytogenetic analysis of complex chromosomal aberrations in bone marrow cells of patients with myelodysplastic syndrome (MDS) and/or acute myeloid leukemia (AML) and AND its contribution for prognosis.
Project goals
Molecular cytogenetic analysis of complex chromosomal aberrations in patients with MDS and AML. Identification of chromosomes and/or chromosomal regions involved in complex karyotypes. Evaluation of the impact of complex rearrangements on prognosis of the patients.
Keywords
Complex chromosomal aberrationMDS and AMLmolecular cytogeneticsmFISH/mBANDPrimary/secondary aberrations
Public support
Provider
Ministry of Health
Programme
Branch programm of research of the Ministry of Health
Call for proposals
VaV pro Ministerstvo zdravotnictví 4 (SMZ02007NR)
Main participants
—
Contest type
VS - Public tender
Contract ID
NR9227-3/2007
Alternative language
Project name in Czech
Molekulárně cytogenetická analýza komplexních chromosomových aberací v buňkách kostní dřeně nemocných s myelodysplastickým syndromem (MDS) a akutní myeloidní leukemií (AML) a jejich prognostická význam.
Annotation in Czech
Molekulárně cytogenetická analýza komplexních chromosomových aberací u nemocných s MDS a AML. Identifikace chromosomů a chromosomových oblastí zahrnutých v komplexních karyotypech. Zhodnocení prognostického významu komplexních přestaveb.
Scientific branches
R&D category
NV - Nonindustrial research (Applied research excluded Industrial research)
CEP classification - main branch
EB - Genetics and molecular biology
CEP - secondary branch
FD - Oncology and haematology
CEP - another secondary branch
—
10603 - Genetics and heredity (medical genetics to be 3)
10604 - Reproductive biology (medical aspects to be 3)
10605 - Developmental biology
10608 - Biochemistry and molecular biology
10609 - Biochemical research methods
30101 - Human genetics
30204 - Oncology
30205 - Hematology
Completed project evaluation
Provider evaluation
V - Vynikající výsledky projektu (s mezinárodním významem atd.)
Project results evaluation
Frequency and prognostic value of complex chromosomal aberrations were evaluated by molecular cytogenetic methods in bone marrow of MDS and AML patients. The worst prognosis was found for patients whose deleted 5q was involved in complex karyotypes.
Solution timeline
Realization period - beginning
Jan 1, 2007
Realization period - end
Dec 31, 2009
Project status
U - Finished project
Latest support payment
Dec 18, 2009
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP10-MZ0-NR-U/03:3
Data delivery date
Apr 27, 2011
Finance
Total approved costs
3,054 thou. CZK
Public financial support
2,953 thou. CZK
Other public sources
101 thou. CZK
Non public and foreign sources
0 thou. CZK
Recognised costs
3 054 CZK thou.
Public support
2 953 CZK thou.
0%
Provider
Ministry of Health
CEP
EB - Genetics and molecular biology
Solution period
01. 01. 2007 - 31. 12. 2009